30.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TVTX Giù?
Forum
Previsione
Frazionamento azionario
Travere Therapeutics Inc Borsa (TVTX) Ultime notizie
Buyback Watch: Is Travere Therapeutics Inc trading at a discount2026 Macro Moves & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Palisades Investment Partners LLC Invests $5.26 Million in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) CEO Eric Dube Sells 60,000 Shares - MarketBeat
Travere Therapeutics (NASDAQ:TVTX) Insider Sells $300,000.00 in Stock - MarketBeat
Travere therapeutics CEO Dube sells $1.8m in TVTX stock By Investing.com - Investing.com Canada
Travere therapeutics chief legal officer sells $300k in TVTX stock - Investing.com
Travere therapeutics chief legal officer sells $300k in TVTX stock By Investing.com - au.investing.com
Travere Therapeutics (TVTX) CEO sells 60K shares after option exercise - Stock Titan
Travere (NASDAQ: TVTX) CLO exercises options, pre-planned sale of 10K shares - Stock Titan
Travere Awaits FDA FILSPARI Ruling As Valuation Gap Draws Attention - finance.yahoo.com
(TVTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
TVTX (NASDAQ: TVTX) files Form 144 for 60,000-share sale - Stock Titan
Elizabeth Reed registers sale of 10,000 TVTX shares (TVTX) via option exercise - Stock Titan
Hennion & Walsh Asset Management Inc. Increases Position in Travere Therapeutics, Inc. $TVTX - MarketBeat
A Look At Travere Therapeutics (TVTX) Valuation After Recent Share Price Pullback - simplywall.st
Tudor Investment Corp Cuts Stake in Travere Therapeutics - National Today
Tudor Investment Corp ET AL Cuts Stake in Travere Therapeutics, Inc. $TVTX - MarketBeat
Travere, CSL gets standard EU approval for kidney disorder treatment - MSN
JPMorgan Chase Cuts Travere Therapeutics Price Target - National Today
Vanguard disaggregates holdings; reports 0 TVTX shares (Vanguard) - Stock Titan
Travere Therapeutics, Inc. $TVTX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
J.P. Morgan Gives a Buy Rating to Travere Therapeutics (TVTX) - The Globe and Mail
Aug Spikes: Should value investors consider Travere Therapeutics Inc2026 Price Swings & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Travere Therapeutics price target lowered to $41 from $44 at JPMorgan - TipRanks
Earnings Risk: Is Cayson Acquisition Corp Equity Right stock a falling knife or bargain buy2026 Volatility Report & High Accuracy Swing Trade Signals - baoquankhu1.vn
FOMO Trade: Is Snail Inc forming bullish engulfing patternsMarket Trend Review & Weekly Top Gainers Trade List - baoquankhu1.vn
JPMorgan Chase & Co. Has Lowered Expectations for Travere Therapeutics (NASDAQ:TVTX) Stock Price - MarketBeat
JP Morgan Lowers Price Target for TVTX to $41.00, Maintains Over - GuruFocus
Travere Therapeutics, Inc. (NASDAQ:TVTX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Travere Therapeutics (TVTX) Gains Attention with Potential FDA A - GuruFocus
Citi opens ‘upside 90-day catalyst watch’ on Travere Therapeutics - TipRanks
Citi Lifts Travere Therapeutics (TVTX) PT to $34 on Strong Q2 and Upcoming FDA Catalysts - MSN
A Look At Travere Therapeutics (TVTX) Valuation After Recent Share Price Volatility - simplywall.st
Travere Therapeutics (TVTX) reports 144% annual growth in Filspari sales for 2025 - MSN
Responsive Playbooks and the TVTX Inflection - Stock Traders Daily
Travere Therapeutics, Inc. (TVTX) positioned for long-term growth in rare disease market - MSN
Highs Report: Can Travere Therapeutics Inc be recession proofShare Buyback & Growth Focused Investment Plans - baoquankhu1.vn
Is Travere Therapeutics (TVTX) Pricing Signal An Opportunity After Recent Share Price Pullback? - simplywall.st
Travere Therapeutics Inc SEC Filings - Stock Titan
TVTX SEC FilingsTravere Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
TVTX Earnings History & Surprises | EPS & Revenue Results | TRAVERE THERAPEUTICS INC (NASDAQ:TVTX) - ChartMill
Travere Therapeutics (NASDAQ:TVTX) Insider Sells $280,900.00 in Stock - MarketBeat
Travere Therapeutics (TVTX) CLO exercises options and sells 10K shares - Stock Titan
HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs - MSN
Cinctive Capital Management LP Makes New $2.26 Million Investment in Travere Therapeutics, Inc. $TVTX - MarketBeat
Earnings Recap: Is Travere Therapeutics Inc stock heavily shorted2026 Technical Patterns & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
[144] Travere Therapeutics, Inc. SEC Filing - Stock Titan
166,000 Shares in Travere Therapeutics, Inc. $TVTX Purchased by Apis Capital Advisors LLC - MarketBeat
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall - Sahm
Understanding the Setup: (TVTX) and Scalable Risk - Stock Traders Daily
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):